Table 2 Comparison of Anti-SARS-CoV-2 QuantiVac between sex,,,,,,,
Variables,"Total
(n = 60)",,"Male
(n = 25)",,"Female
(n = 35)",,p-value
"Quantivac level, (RU/ml)",43.88,(25.93 - 96.51),34.95,(22.96 - 61.48),49.89,(31.37 - 116.19),0.027a
"Quantivac level, (BAU/ml)",140.4,(82.97 - 308.83),111.83,(73.48 - 196.74),159.65,(100.39 - 371.81),0.027a
Quantivac Value,,,,,,,
Negative,1,(1.7),1,(4.0),0,(0.0),0.382b
Borderline,3,(5.0),2,(8.0),1,(2.9),
Positive,56,(93.3),22,(88.0),34,(97.1),
"Neutralising Ab, (%IH)",42.67,(26.69 - 62.55),32.06,(21.48 - 47.10),49.81,(29.88 - 66.08),0.021a
Negative,8,(13.3),6,(24.0),2,(5.7),0.048b
Borderline,16,(26.7),8,(32.0),8,(22.9),
Positive,36,(60.0),11,(44.0),25,(71.4),
"Values are number of patients (%) or median (interquartile range, 25th and 75th percentiles).",,,,,,,
aWilcoxon rank-sum test,,,,,,,
bFisher's exact test,,,,,,,